Suchergebnisse - "Savvidou, Ioanna"

PubPharm (21)

1

Development of endothelial-targeted CD39 as a therapy for ischaemic stroke

enthalten in: bioRxiv.org | 2023

von Lee, N. | Savvidou, I. | Selan, C. | +11

2

Combination of Histone Deacetylase Inhibitor Panobinostat (LBH589) with β-Catenin Inhibitor Tegavivint (BC2059) Exerts Significant Anti-Myeloma Activity Both In Vitro and In Vivo

enthalten in: Cancers | 2022

von Savvidou, I. | Khong, T. | Whish, S. | +6

3

Correction : Liquid biopsy: an evolving paradigm for the biological characterisation of plasma cell disorders

enthalten in: Leukemia | 2021

von Mithraprabhu, S. | Chen, M. | Savvidou, I. | +2

ErratumFor: Leukemia. 2021 Oct;35(10):2771-2783. - PMID 34262132

4

Liquid biopsy : an evolving paradigm for the biological characterisation of plasma cell disorders

enthalten in: Leukemia | 2021

von Mithraprabhu, S. | Chen, M. | Savvidou, I. | +2

ErratumIn: Leukemia. 2021 Sep 20;:. - PMID 34545186

5

Human myeloma cell- and plasma-derived extracellular vesicles contribute to functional regulation of stromal cells

enthalten in: Proteomics | 2021

von Reale, A. | Carmichael, I. | Xu, R. | +10

6

Phase II trial of single-agent panobinostat consolidation improves responses after sub-optimal transplant outcomes in multiple myeloma

enthalten in: British journal of haematology | 2021

von Mithraprabhu, S. | Kalff, A. | Gartlan, K. | +8

7

TOP2A expression predicts responsiveness to carfilzomib in myeloma and informs novel combinatorial strategies for enhanced proteasome inhibitor cell killing

enthalten in: Leukemia & lymphoma | 2021

von Reale, A. | Khong, T. | Mithraprabhu, S. | +11

8

Human myeloma cell‐ and plasma‐derived extracellular vesicles contribute to functional regulation of stromal cells

enthalten in: PROTEOMICS | 2021

von Reale, A. | Carmichael, I. | Xu, R. | +10

9

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

enthalten in: Leukemia | 2019

von Mithraprabhu, S. | Morley, R. | Khong, T. | +10

10

β-Catenin Inhibitor BC2059 Is Efficacious as Monotherapy or in Combination with Proteasome Inhibitor Bortezomib in Multiple Myeloma

enthalten in: Molecular cancer therapeutics | 2017

von Savvidou, I. | Khong, T. | Cuddihy, A. | +3